Overview

Pharmacokinetic Interactions Between Hydronidone and Entecavir Capsules in Healthy Chinese Subjects

Status:
Completed
Trial end date:
2019-08-13
Target enrollment:
Participant gender:
Summary
This study, by comparing the Hydronidone capsules and entecavir capsule in a single dose and steady-state dosing state of both the level of blood drug concentration, assess Hydronidone capsules and entecavir capsule for interaction。
Phase:
Phase 1
Details
Lead Sponsor:
Beijing Continent Pharmaceutical Co, Ltd.
Treatments:
Entecavir